# Study in Subjects With Light Chain (AL) Amyloidosis

> **NCT03154047** · PHASE2 · TERMINATED · sponsor: **Prothena Biosciences Ltd.** · enrollment: 80 (actual)

## Conditions studied

- AL Amyloidosis

## Interventions

- **DRUG:** NEOD001

## Key facts

- **NCT ID:** NCT03154047
- **Lead sponsor:** Prothena Biosciences Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-06-14
- **Primary completion:** 2018-05-30
- **Final completion:** 2018-05-30
- **Target enrollment:** 80 (ACTUAL)
- **Why stopped:** NEOD001 program terminated due to lack of clinical benefit
- **Last updated:** 2019-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03154047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03154047, "Study in Subjects With Light Chain (AL) Amyloidosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03154047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*